MONALIZUMAB
UNII 3ZXZ2V0588

Substance Identification & Data

This profile provides standardized clinical and technical data for Monalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3ZXZ2V0588.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1228763-95-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3ZXZ2V0588

CAS Registry Number

1228763-95-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MONALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C120208

National Cancer Institute reference terminology for clinical and research data.

INN ID

10113

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-264

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Monalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MONALIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN NKG2A/CD94 RECEPTOR) (HUMAN-MOUSE MONOCLONAL HUMZ270 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HUMZ270 LIGHT CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS KLRC1 (KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY C MEMBER 1, NKG2-A, NKG2A, CD159A, CD94)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN (1-452) (HUMANIZED VH (HOMO SAPIENS IGHV1-18*01 (89.80%)-(IGHD)-IGHJ2*01 R120>Q(117), L123>T(130))(8.8.18)(1-125)), IGHG4*01 (CH1 (126-223), HINGE S10>P (233) (224-235), CH2 (236-345), CH3 (346-450), CHS (451-452))(126-452)),(139-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-39*01 (87.40%) - IGKJ4*01) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01, KM3 (108'-214')); DIMER (231-231'': 234-234'')-BISDISULFIDE

IPH-2201

MONALIZUMAB [INN]

MONALIZUMAB [USAN]

MONALIZUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS KLRC1 (KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY C MEMBER 1, NKG2-A, NKG2A, CD159A, CD94)), HUMANIZED MONOCLONAL ANTIBODY

SYS